“Tailored” antiplatelet bridging therapy with cangrelor: moving toward personalized medicine-Reference-Cited by-同舟云学术

“Tailored” antiplatelet bridging therapy with cangrelor: moving toward personalized medicine

Published:2021-10-21 Issue: Volume: Page:1-5
ISSN:0953-7104
Container-title:Platelets
language:en
Short-container-title:Platelets

Author:

Valenti Renato¹,Muraca Iacopo¹,Marcucci Rossella²,Ciatti Francesca¹^ORCID,Berteotti Martina²,Gori Anna Maria²,Carrabba Nazario¹,Migliorini Angela¹,Marchionni Niccolò¹,Valgimigli Marco³

Affiliation:

1. From the Interventional Cardiology Unit, Cardiovascular Department, Careggi University Hospital, Florence, Italy

2. From the Department of Clinical and Experimental Medicine, University of Florence, Florence, Italy

3. Division of Cardiology, Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale (Eoc), Lugano, Switzerland; Department of Cardiology, University of Bern, Bern, Switzerland

Funder

no funding

Publisher

Informa UK Limited

Subject

Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/09537104.2021.1983162

Reference23 articles.

1. Perioperative Management of Patients With Coronary Stents

2. Management of Antiplatelet Therapy in Patients With Coronary Artery Disease Requiring Cardiac and Noncardiac Surgery

3. Risk of Adverse Cardiac and Bleeding Events Following Cardiac and Noncardiac Surgery in Patients With Coronary Stent